United Kingdom · Question · Written question
UIN 23967
Givinostat
Introduced
14 January 2025
Last action
20 January 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 January 2025
Summary
To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on the potential merits of offering Givinostat for Duchenne muscular dystrophy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
14 January 2025
Written question
To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on the potential merits of offering Givinostat for Duchenne muscular dystrophy.
Source: Commons
20 January 2025
Answer
There are no plans to have discussions with the National Institute for Health and Care Excellence (NICE) on offering givinostat for Duchenne muscular dystrophy. The NICE makes recommendations for the National Health Service on whether new licensed medicin...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-01-14/23967
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1755362
- uk · wq-1755362 · source updated 20 January 2025